Lee, A. Y., Lee, C. S., Butt, T., Xing, W., Johnston, R. L., Chakravarthy, U., . . . Tufail, A. (2015). UK AMD EMR USERS GROUP REPORT V: Benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12. Br J Ophthalmol.
Chicago ZitierstilLee, Aaron Y., et al. "UK AMD EMR USERS GROUP REPORT V: Benefits of Initiating Ranibizumab Therapy for Neovascular AMD in Eyes With Vision Better Than 6/12." Br J Ophthalmol 2015.
MLA ZitierstilLee, Aaron Y., et al. "UK AMD EMR USERS GROUP REPORT V: Benefits of Initiating Ranibizumab Therapy for Neovascular AMD in Eyes With Vision Better Than 6/12." Br J Ophthalmol 2015.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.